OLR1 and liver disorder: In addition, Lox-1 overexpression promotes vascular dysfunction and atherosclerotic and liver diseases; thus, targeting or blocking Lox-1 is a potential therapeutic strategy to reduce the detrimental consequence of ox-LDL uptake.